Comparative Study of Endometrial Polypectomy Performed With Bipolar Electrode Versapoint and Laser Diode. A Randomised Controlled Trial.
1 other identifier
interventional
98
1 country
2
Brief Summary
Hysteroscopy today is considered the gold standard for the diagnosis and treatment of endometrial polyps. In recent years we have used the bipolar energy for resection of polyps by hysteroscopy, becoming a routine clinical practice and universally accepted. Resection of endometrial polyps laser energy has recently begun to be used with satisfactory results, so studies are needed to analyze these results and compare it with the usual techniques . This time in advance of medicine, it is appropriate to introduce minimally invasive procedures , allowing resection of endometrial polyps on an outpatient basis without anesthesia and acceptable to most patients. These procedures assume a lower cost and are associated with a lower surgical risk due to their realization without anesthesia . Hypothesis: Resection of polyps outpatient laser diode has a similar or superior to that of the bipolar electrode tolerability. The diode laser is a viable , quick , simple technique with a high percentage of resection and high degree of satisfaction of patients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2013
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2013
CompletedFirst Submitted
Initial submission to the registry
January 28, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2014
CompletedFirst Posted
Study publicly available on registry
April 30, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2014
CompletedJuly 10, 2014
July 1, 2014
10 months
January 28, 2014
July 8, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To assess the tolerability of the laser diode in the treatment of endometrial polyps using a validated visual analogue pain scale
we we measure pain after resection of endometrial polyps, with 5 minutes for the patient thinks
Secondary Outcomes (3)
Determine if complete resection of polyps is achieved with both methods.
the duration of the polyp resection, subsequent assessment of the patient and her general condition. Time is measured, between 15 to 30 minutes
Compare the time spent on the removal of the polyp.
the duration of the polyp resection, subsequent assessment of the patient and her general condition. Time is measured, between 15 to 30 minutes
To evaluate the safety of both methods
the duration of the polyp resection, subsequent assessment of the patient and her general condition. Time is measured, between 15 to 30 minutes
Other Outcomes (2)
Assess the recurrence of polyps after 3 months of resection (another hysteroscopy).
3 months after resection of the polyp, repeat hysteroscopy to assess recurrence, in 10 to 15 minutes. the patient is satisfied if foretaste and whether they would recommend the procedure.
Compare the degree of patient satisfaction with the different methods
3 months after resection of the polyp, repeat hysteroscopy to assess recurrence, in 10 to 15 minutes. the patient is satisfied if foretaste and whether they would recommend the procedure.
Study Arms (2)
polyps resection with Laser Diode
ACTIVE COMPARATORapplication of the laser diode by hysteroscopy to remove the endometrial polyp
polyps resection with bipolar electrode
ACTIVE COMPARATORapplication of the bipolar electrode Versapoint by hysteroscopy to remove the endometrial polyp
Interventions
resection of endometrial polyps by hysteroscopy without anesthesia
Eligibility Criteria
You may qualify if:
- patients previously diagnosed of endometrial polyps that can be resected. The diagnosis will be made hysteroscopically. The patient must be informed about the study, and sign the informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Isabel Bejerano Blázquezlead
- Hospital Universitario Reina Sofia de Cordobacollaborator
- Universidad Nacional de Córdobacollaborator
Study Sites (2)
Reina Sofia University Hospital
Córdoba, Cordoba, 14004, Spain
Reina Sofía University Hospital
Córdoba, Cordoba, 14004, Spain
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
José Eduardo Arjona Berral, Gynecologist
Head of the Department of Obstetrics and Gynecology at the University Hospital Reina Sofia
- PRINCIPAL INVESTIGATOR
Maria Dolores Lara, Gynecologist
Physician specializing in obstetrics and gynecology.
- STUDY CHAIR
Rafaela Dios Palomares, Engineer
Universidad de Córdoba
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- IMIBIC
Study Record Dates
First Submitted
January 28, 2014
First Posted
April 30, 2014
Study Start
May 1, 2013
Primary Completion
March 1, 2014
Study Completion
May 1, 2014
Last Updated
July 10, 2014
Record last verified: 2014-07